Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Psychoneuroendocrinology. 2018 Oct 2;100:223–228. doi: 10.1016/j.psyneuen.2018.09.039

Figure 1.

Figure 1.

Hippocampus volume for males with KS in the placebo and treatment (oxandrolone) groups and for typically developing males without KS (TD controls). Error bars indicate standard deviation.